干细胞治疗在过敏性疾病治疗中的机制研究进展OA
Research progress on the mechanism of stem cell therapy in the treatment of allergic dis-eases
过敏性疾病是主要由 IgE 介导的Ⅰ型变态反应,可累及全身多个器官和系统,是世界范围的公共健康问题.其病因复杂,发病机制尚未完全阐明,目前治疗药物如抗组胺药、糖皮质激素等,仅能控制症状,不能阻止过敏进程.干细胞治疗已被证实在过敏性疾病治疗中具有巨大潜力,但具体作用机制尚不明确.本文从干细胞治疗在过敏性疾病中的治疗机制进行综述,寻找针对性治疗靶点,为研发新型治疗方法和药物提供理论依据.
Allergic diseases are mainly type I allergic reactions mediated by IgE,which can involve multiple organs and systems in the whole body,and are a worldwide public health problem.The etiology of al-lergic diseases is complex and the pathogenesis has not been fully elucidated.Current treatments,such as anti-histamines and glucocorticoids,can only control symptoms,but cannot stop the allergic process. Stem cell therapy has been proven to have great potential in the treatment of allergic diseases,but the spe-cific mechanism of action is still unclear.In this paper,the therapeutic mechanism of stem cell therapy in aller-gic diseases was reviewed,and targeted therapeutic targets were sought to provide theoretical basis for the de-velopment of novel therapeutic methods and drugs.
胡凤侠;李屹洲;梁俊琴
830001 乌鲁木齐,新疆维吾尔自治区人民医院变态反应(过敏)科830001 乌鲁木齐,新疆维吾尔自治区人民医院变态反应(过敏)科||830001 乌鲁木齐,新疆维吾尔自治区人民医院博士后科研工作站830001 乌鲁木齐,新疆维吾尔自治区人民医院中西医协同医学诊疗中心、中西医结合疑难危重疾病临床研究中心
干细胞间充质干细胞干细胞治疗过敏性疾病
stem cellsmesenchymal stem cellsstem cell therapyallergic disease
《中华临床免疫和变态反应杂志》 2026 (4)
371-376,6
新疆维吾尔自治区人民医院-干细胞生物治疗基础和临床研究专项项目(GXBZX-2023004)新疆维吾尔自治区"天山创新团队计划"项目(2023D14005) Basic and clinical research project of stem cell biotherapy-People's Hospital of Xinjiang Uygur Autonomous Region(GXBZX-2023004)Tianshan Innovation Team Fund Project of Xinjiang Uygur Au-tonomous Region(2023D14005)
评论